Skip to content
StockMarketAgent
Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

NZE/RYM stock hub

NZE/RYM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

NZE/RYMis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2.3B
New Zealand Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
NZE/RYM
In the news

Latest news · NZE/RYM

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.7
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-13.4
P25 n/aP50 n/aP75 n/a
ROIC0.1
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All NZE/RYM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
215
Groups with data
11
Currency
NZD
Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
New Zealand
Country code
NZ
Employees
7,700
Employees Change
500%
Employees Change Percent
6.94
Enterprise value
NZD 3.9B
Exchange
New Zealand Stock Exchange
Financial currency
NZD
First seen
2026-05-10
Industry
Medical Care Facilities
Isin
NZRYME0001S4
Last refreshed
2026-05-10
Market cap
NZD 2.3B
Price
NZD 2.23
Price currency
NZD
Rev Per Employee
104,867.66x
Sector
Healthcare
Sic
8300
Symbol
nze/RYM
Website
https://www.rymanhealthcare.co.nz

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

10
MetricValue
Earnings Yield
-24.93%
EV Earnings
-7x
EV/EBITDA
91.27x
EV/FCF
15.09x
EV/Sales
4.89x
FCF yield
11.57%
Forward P/E
18.74x
P/B ratio
0.55x
P/S ratio
2.8x
PE Ratio10 Y
19.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

19
MetricValue
EBIT Margin
0.93%
EBITDA Margin
4.88%
FCF margin
32.41%
Gross margin
6.55%
Gross Profit
NZD 52.9M
Gross Profit Growth
555.01%
Gross Profit Growth5 Y
6.03%
Net Income
NZD -564M
Net Income Growth Years
0%
Pretax Margin
-52.59%
Profit Margin
-69.85%
Profit Per Employee
NZD -73,250
ROA
0.04
Roa5y
-0.06
ROCE
0.12
ROE
-13.37
Roe5y
6.01
ROIC
0.13
Roic5y
-0.19

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

25
MetricValue
Cagr10y
-10.69%
Cagr15y
1.62%
Cagr1y
-8.99%
Cagr20y
4.78%
Cagr3y
-23.09%
Cagr5y
-28.34%
Div CAGR10
9.43%
Div CAGR3
-1.45%
Div CAGR5
3.57%
EPS Growth Years
0
FCF Growth
-13.98%
FCF Growth Q
5.1%
FCF Growth3 Y
-8.03%
FCF Growth5 Y
3.63%
OCF Growth
-38.41%
OCF Growth Q
-33.78%
OCF Growth10 Y
1.05%
OCF Growth3 Y
-18.52%
OCF Growth5 Y
-12.89%
Revenue Growth
12.1x
Revenue Growth Q
13.23x
Revenue Growth Quarters
35x
Revenue Growth Years
17x
Revenue Growth3 Y
5.51x
Revenue Growth5 Y
6.78x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
NZD 0.06
Assets
NZD 12.1B
Cash
NZD 9.4M
Current Assets
NZD 193.6M
Current Liabilities
NZD 6.1B
Debt
NZD 1.7B
Debt EBITDA
NZD 39.2
Debt Equity
NZD 0.41
Debt FCF
NZD 6.48
Equity
NZD 4.1B
Interest Coverage
0.04
Liabilities
NZD 8B
Long Term Assets
NZD 12B
Long Term Liabilities
NZD 1.9B
Net Cash
NZD -1.7B
Net Cash By Market Cap
NZD -74.56
Net Debt EBITDA
NZD 42.82
Net Debt Equity
NZD 0.41
Net Debt FCF
NZD 6.45
Tangible Book Value
NZD 4.1B
Tangible Book Value Per Share
NZD 4.06
WACC
6.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.03
Inventory Turnover
799.4
Net Working Capital
NZD -5.9B
Quick ratio
0.01
Working Capital
NZD -5.9B
Working Capital Turnover
NZD -0.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-27.13%
Dividend per share
NZD 0
Last Dividend
NZD 0.09

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-67.7%
1Y total return
-8.98%
200-day SMA
2.58
3Y total return
-54.51%
50-day SMA
2.2
50-day SMA vs 200-day SMA
50under200
5Y total return
-81.1%
All Time High
17.2
All Time High Change
-87.03%
All Time High Date
2019-12-30
All Time Low
0.13
All Time Low Change
1,643.55%
All Time Low Date
1999-09-08
ATR
0.09
Beta
0.33
Beta1y
-0.36
Beta2y
-0.06
Ch YTD
-23.37
High
2.25
High52
3.05
High52 Date
2026-01-13
High52ch
-26.89%
Low
2.18
Low52
2
Low52 Date
2026-04-20
Low52ch
11.78%
Ma50ch
1.46%
Price vs 200-day SMA
-13.7%
RSI
54
RSI Monthly
33.78
RSI Weekly
40.24
Sharpe ratio
-0.21x
Sortino ratio
-0.13
Total Return
-27.13%
Tr YTD
-23.37
Tr15y
27.32%
Tr1m
4.21%
Tr1w
2.77%
Tr3m
-18.91%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

3
MetricValue
Operating Income
NZD 7.5M
Operating Income Growth5 Y
34.09
Operating margin
0.93

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
986,949,375%
Net Borrowing
-977,899,000
Shares Insiders
2.74%
Shares Institutions
46.68%
Shares Out
1,014,717,719
Shares Qo Q
38.62%
Shares Yo Y
27.13%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

61
MetricValue
Adjusted FCF
NZD 259.3M
Average Volume
1,508,793.4x
Bv Per Share
4.08
CAPEX
NZD -60.3M
Ch10y
-75.41
Ch15y
-12.55
Ch1m
4.21
Ch1w
2.77
Ch1y
-8.98
Ch20y
52.74
Ch3m
-18.91
Ch3y
-57.92
Ch5y
-84.25
Ch6m
-24.41
Change
-0.89%
Change From Open
-0.89
Close
2.25
Days Gap
0
Depreciation Amortization
31,864,000
Dollar Volume
1,575,057.9
Earnings Date
2026-05-26
EBIT
NZD 7.5M
EBITDA
NZD 39.4M
EPS
NZD -0.65
F Score
6
FCF
NZD 261.7M
FCF EV Yield
6.63x
FCF Per Share
NZD 0.26
Financing CF
-4,693,000
Fiscal Year End
March
Founded
1,984
Income Tax
NZD 139.4M
Investing CF
-331,024,000
Is Primary Listing
1
Last Earnings Date
2026-02-26
Last Report Date
2025-09-30
Last Split Date
2007-01-29
Last Split Type
Forward
Ma150
2.62
Ma150ch
-14.98%
Ma20
2.14
Ma20ch
4.25%
Net CF
-13,660,000
Next Earnings Date
2026-05-26
Open
2.25
P FCF Ratio
8.65
P OCF Ratio
7.03
Position In Range
71.43
Ppne
1,029,987,000
Price Date
2026-05-08
Price EBITDA
NZD 57.43
Ptbv Ratio
0.55
Relative Volume
0.48x
Revenue
807,481,000x
SBC By Revenue
0.3x
Share Based Comp
2,431,000
Tax By Revenue
17.26x
Tr20y
154.49%
Tr6m
-24.41%
Volume
706,304
Z Score
-0.07
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does NZE/RYM pay a dividend?

Capital-return profile for this ticker.

Performance

NZE/RYM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-9.0%
S&P 500 1Y: n/a
3Y total return
-54.5%
S&P 500 3Y: n/a
5Y total return
-81.1%
S&P 500 5Y: n/a
10Y total return
-67.7%
S&P 500 10Y: n/a
Ownership

Who owns NZE/RYM?

Insider, institutional, and short-interest positioning.

Institutional ownership
+46.7%
Share of float held by funds and institutions
Insider ownership
+2.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+27.1%
Negative means the company is buying back shares.
Technical

NZE/RYM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
54.0
Neutral momentum band
Price vs 200-day MA
-13.7%
50/200-day relationship not available
Beta (5Y)
0.33
Less volatile than the market
Sharpe ratio
-0.21
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About NZE/RYM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nze/RYM stock rating?

nze/RYM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nze/RYM analysis?

The full report lives at /stocks/nze/RYM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nze/RYM?

The latest report frames nze/RYM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nze/RYM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.